Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3760
-0.0340 (-8.29%)
At close: Apr 1, 2025, 4:00 PM
0.3879
+0.0119 (3.18%)
After-hours: Apr 1, 2025, 4:25 PM EDT

Turnstone Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
91159--
Market Cap Growth
-80.45%-80.45%---
Enterprise Value
-35-32-47--
Last Close Price
0.410.502.54--
PS Ratio
-3.04--
PB Ratio
0.220.260.60--
P/TBV Ratio
0.260.260.60--
Debt / Equity Ratio
0.040.040.030.070.03
Debt / EBITDA Ratio
----0.07
Asset Turnover
--0.170.49-
Quick Ratio
--7.932.613.05
Current Ratio
--8.572.813.23
Return on Equity (ROE)
-99.55%-99.55%-65.27%-38.45%-
Return on Assets (ROA)
---32.34%-10.18%-
Return on Capital (ROIC)
-61.55%-61.55%-41.49%-18.28%-
Return on Capital Employed (ROCE)
----26.20%
Earnings Yield
-799.68%-616.37%-93.92%--
FCF Yield
--114.68%--
Buyback Yield / Dilution
-99.23%-99.23%-365.39%7.96%-
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q